Stryker Gross Margin 2012-2026 | SYK
Current and historical gross margin for Stryker (SYK) over the last 10 years. The current gross profit margin for Stryker as of March 31, 2026 is %.
| Stryker Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2026-03-31 | $25.27B | $16.13B | 63.83% |
| 2025-12-31 | $25.12B | $16.07B | 63.96% |
| 2025-09-30 | $24.38B | $15.61B | 64.03% |
| 2025-06-30 | $23.82B | $15.28B | 64.14% |
| 2025-03-31 | $23.22B | $14.85B | 63.96% |
| 2024-12-31 | $22.60B | $14.44B | 63.91% |
| 2024-09-30 | $21.97B | $13.97B | 63.57% |
| 2024-06-30 | $21.39B | $13.61B | 63.63% |
| 2024-03-31 | $20.96B | $13.38B | 63.80% |
| 2023-12-31 | $20.50B | $13.06B | 63.70% |
| 2023-09-30 | $19.89B | $12.59B | 63.32% |
| 2023-06-30 | $19.46B | $12.22B | 62.79% |
| 2023-03-31 | $18.95B | $11.86B | 62.58% |
| 2022-12-31 | $18.45B | $11.58B | 62.76% |
| 2022-09-30 | $17.95B | $11.39B | 63.44% |
| 2022-06-30 | $17.63B | $11.25B | 63.80% |
| 2022-03-31 | $17.43B | $11.19B | 64.22% |
| 2021-12-31 | $17.11B | $10.97B | 64.11% |
| 2021-09-30 | $16.67B | $10.64B | 63.83% |
| 2021-06-30 | $16.25B | $10.46B | 64.38% |
| 2021-03-31 | $14.72B | $9.24B | 62.75% |
| 2020-12-31 | $14.35B | $9.06B | 63.11% |
| 2020-09-30 | $14.22B | $9.04B | 63.59% |
| 2020-06-30 | $14.07B | $8.91B | 63.34% |
| 2020-03-31 | $14.96B | $9.74B | 65.15% |
| 2019-12-31 | $14.88B | $9.70B | 65.14% |
| 2019-09-30 | $14.55B | $9.45B | 64.95% |
| 2019-06-30 | $14.20B | $9.27B | 65.29% |
| 2019-03-31 | $13.88B | $9.08B | 65.47% |
| 2018-12-31 | $13.60B | $8.94B | 65.72% |
| 2018-09-30 | $13.28B | $8.72B | 65.71% |
| 2018-06-30 | $13.04B | $8.55B | 65.58% |
| 2018-03-31 | $12.73B | $8.35B | 65.62% |
| 2017-12-31 | $12.44B | $8.18B | 65.73% |
| 2017-09-30 | $12.13B | $8.03B | 66.23% |
| 2017-06-30 | $11.96B | $7.92B | 66.26% |
| 2017-03-31 | $11.79B | $7.77B | 65.97% |
| 2016-12-31 | $11.33B | $7.50B | 66.26% |
| 2016-09-30 | $10.88B | $7.23B | 66.42% |
| 2016-06-30 | $10.47B | $6.98B | 66.67% |
| 2016-03-31 | $10.06B | $6.74B | 67.01% |
| 2015-12-31 | $9.95B | $6.60B | 66.38% |
| 2015-09-30 | $9.85B | $6.50B | 66.01% |
| 2015-06-30 | $9.82B | $6.44B | 65.56% |
| 2015-03-31 | $9.75B | $6.38B | 65.44% |
| 2014-12-31 | $9.68B | $6.36B | 65.70% |
| 2014-09-30 | $9.53B | $6.23B | 65.39% |
| 2014-06-30 | $9.29B | $6.14B | 66.08% |
| 2014-03-31 | $9.14B | $6.07B | 66.45% |
| 2013-12-31 | $9.02B | $6.02B | 66.72% |
| 2013-09-30 | $8.89B | $6.02B | 67.72% |
| 2013-06-30 | $8.79B | $5.95B | 67.66% |
| 2013-03-31 | $8.69B | $5.90B | 67.94% |
| 2012-12-31 | $8.66B | $5.88B | 67.88% |
| 2012-09-30 | $8.53B | $5.76B | 67.47% |
| 2012-06-30 | $8.51B | $5.72B | 67.23% |
| 2012-03-31 | $8.45B | $5.62B | 66.51% |
| 2011-12-31 | $8.31B | $5.50B | 66.16% |
| 2011-09-30 | $8.09B | $5.39B | 66.66% |
| 2011-06-30 | $7.82B | $5.26B | 67.18% |
| 2011-03-31 | $7.54B | $5.14B | 68.23% |
| 2010-12-31 | $7.32B | $5.03B | 68.77% |
| 2010-09-30 | $7.16B | $4.91B | 68.52% |
| 2010-06-30 | $7.04B | $4.79B | 68.04% |
| 2010-03-31 | $6.92B | $4.67B | 67.51% |
| 2009-12-31 | $6.72B | $4.54B | 67.54% |
| 2009-09-30 | $6.61B | $4.46B | 67.53% |
| 2009-06-30 | $6.61B | $4.46B | 67.47% |
| 2009-03-31 | $6.69B | $4.54B | 67.88% |
| 2008-12-31 | $6.72B | $4.59B | 68.26% |
| 2008-09-30 | $6.66B | $4.56B | 68.46% |
| 2008-06-30 | $6.46B | $4.44B | 68.80% |
| 2008-03-31 | $6.21B | $4.28B | 68.98% |
| 2007-12-31 | $6.00B | $4.14B | 68.91% |
| 2007-09-30 | $5.68B | $3.95B | 69.57% |
| 2007-06-30 | $5.45B | $3.80B | 69.66% |
| 2007-03-31 | $5.25B | $3.65B | 69.46% |
| 2006-12-31 | $5.15B | $3.53B | 68.58% |
| 2006-09-30 | $4.83B | $3.38B | 69.96% |
| 2006-06-30 | $4.77B | $3.29B | 68.92% |
| 2006-03-31 | $4.73B | $3.22B | 68.02% |
| 2005-12-31 | $4.61B | $3.12B | 67.70% |
| 2005-09-30 | $4.75B | $3.06B | 64.51% |
| 2005-06-30 | $4.61B | $2.97B | 64.53% |
| 2005-03-31 | $4.43B | $2.86B | 64.43% |
| 2004-12-31 | $4.26B | $2.75B | 64.49% |
| 2004-09-30 | $4.11B | $2.65B | 64.61% |
| 2004-06-30 | $3.96B | $2.55B | 64.25% |
| 2004-03-31 | $3.81B | $2.43B | 63.83% |
| 2003-12-31 | $3.63B | $2.31B | 63.81% |
| 2003-09-30 | $3.45B | $2.19B | 63.37% |
| 2003-06-30 | $3.31B | $2.10B | 63.28% |
| 2003-03-31 | $3.16B | $2.00B | 63.34% |
| 2002-12-31 | $3.01B | $1.90B | 63.11% |
| 2002-09-30 | $2.89B | $1.83B | 63.08% |
| 2002-06-30 | $2.77B | $1.75B | 63.27% |
| 2002-03-31 | $2.67B | $1.69B | 63.08% |
| 2001-12-31 | $2.60B | $1.64B | 62.99% |
| 2001-09-30 | $2.50B | $1.59B | 63.58% |
| 2001-06-30 | $2.43B | $1.56B | 63.91% |
| 2001-03-31 | $2.36B | $1.52B | 64.25% |
| 2000-12-31 | $2.29B | $1.48B | 64.48% |
| 2000-09-30 | $2.24B | $1.42B | 63.55% |
| 2000-06-30 | $2.19B | $1.32B | 60.49% |
| 2000-03-31 | $2.14B | $1.22B | 56.88% |
| 1999-12-31 | $2.10B | $1.11B | 52.97% |
| 1999-09-30 | $1.87B | $0.95B | 50.72% |
| 1999-06-30 | $1.63B | $0.84B | 51.57% |
| 1999-03-31 | $1.37B | $0.74B | 53.61% |
| 1998-12-31 | $1.10B | $0.63B | 57.21% |
| 1998-09-30 | $1.04B | $0.61B | 58.88% |
| 1998-06-30 | $1.01B | $0.60B | 59.33% |
| 1998-03-31 | $0.99B | $0.59B | 59.66% |
| 1997-12-31 | $0.98B | $0.58B | 59.49% |
| 1997-09-30 | $0.97B | $0.56B | 57.48% |
| 1997-06-30 | $0.96B | $0.55B | 57.17% |
| 1997-03-31 | $0.93B | $0.53B | 56.97% |
| 1996-12-31 | $0.91B | $0.52B | 56.81% |
| 1996-09-30 | $0.89B | $0.52B | 58.25% |
| 1996-06-30 | $0.87B | $0.51B | 58.14% |
| 1996-03-31 | $0.88B | $0.51B | 57.65% |
| 1995-12-31 | $0.87B | $0.50B | 57.68% |
| 1995-09-30 | $0.85B | $0.49B | 57.91% |
| 1995-06-30 | $0.82B | $0.47B | 57.54% |
| 1995-03-31 | $0.75B | $0.43B | 57.03% |
| 1994-12-31 | $0.68B | $0.38B | 55.87% |
| 1994-09-30 | $0.62B | $0.34B | 54.66% |
| 1994-06-30 | $0.59B | $0.32B | 54.19% |
| 1994-03-31 | $0.57B | $0.31B | 53.94% |
| 1993-12-31 | $0.56B | $0.30B | 54.04% |
| 1993-09-30 | $0.54B | $0.29B | 53.87% |
| 1993-06-30 | $0.52B | $0.28B | 53.83% |
| 1993-03-31 | $0.50B | $0.27B | 53.71% |
| 1992-12-31 | $0.48B | $0.26B | 53.46% |
| 1992-09-30 | $0.45B | $0.24B | 53.13% |
| 1992-06-30 | $0.42B | $0.22B | 52.97% |
| 1992-03-31 | $0.39B | $0.21B | 52.67% |
| 1991-12-31 | $0.37B | $0.19B | 52.46% |
| 1991-09-30 | $0.34B | $0.18B | 52.19% |
| 1991-06-30 | $0.32B | $0.17B | 52.02% |
| 1991-03-31 | $0.30B | $0.16B | 52.33% |
| 1990-12-31 | $0.28B | $0.15B | 52.48% |
| 1990-09-30 | $0.26B | $0.14B | 52.65% |
| 1990-06-30 | $0.25B | $0.13B | 52.99% |
| 1990-03-31 | $0.24B | $0.13B | 52.50% |
| 1989-12-31 | $0.23B | $0.12B | 52.21% |
| 1989-09-30 | $0.21B | $0.11B | 52.34% |
| 1989-06-30 | $0.20B | $0.11B | 52.22% |
| 1989-03-31 | $0.19B | $0.10B | 52.63% |
| 1988-12-31 | $0.18B | $0.09B | 52.51% |
| 1988-09-30 | $0.17B | $0.09B | 52.38% |
| 1988-06-30 | $0.16B | $0.08B | 52.17% |
| 1988-03-31 | $0.15B | $0.08B | 51.95% |
| 1987-12-31 | $0.15B | $0.08B | 51.35% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $129.889B | $25.116B |
| Stryker Corporation is a medical device company operating in the global orthopedic market. The company has three business segments: Orthopaedics, MedSurg and Neurotechnology & Spine. Orthopaedic?products include implants used in hip and knee joint replacements and trauma and extremities surgeries. MedSurg?products consists of surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment and reprocessed and remanufactured medical devices. Neurotechnology & Spine division includes both neurosurgical and neurovascular devices. These includes products used for minimally invasive endovascular techniques; traditional brain and open skull base surgical procedures; orthobiologic and biosurgery products and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. Spinal implant product offering includes cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $174.688B | 19.48 |
| Medtronic (MDT) | Ireland | $111.968B | 15.57 |
| EssilorLuxottica (ESLOY) | France | $107.724B | 0.00 |
| Boston Scientific (BSX) | United States | $91.831B | 20.26 |
| Medline (MDLN) | United States | $59.904B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $45.712B | 0.00 |
| GE HealthCare Technologies (GEHC) | United States | $33.391B | 15.98 |
| ResMed (RMD) | United States | $33.341B | 22.26 |
| Agilent Technologies (A) | United States | $32.516B | 20.44 |
| Koninklijke Philips (PHG) | Netherlands | $27.260B | 16.18 |
| Terumo (TRUMY) | Japan | $19.854B | 23.21 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.025B | 11.36 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $14.227B | 0.00 |
| Insulet (PODD) | United States | $13.640B | 39.54 |
| Baxter (BAX) | United States | $8.854B | 7.56 |
| Sunny Optical Technology (SNPTF) | China | $8.381B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.537B | 28.15 |
| Demant (WILYY) | Denmark | $6.395B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $5.247B | 15.90 |
| Envista Holdings (NVST) | United States | $4.301B | 21.99 |
| BillionToOne (BLLN) | United States | $3.729B | 0.00 |
| DiaSorin S.p.A (DSRLF) | Italy | $3.666B | 0.00 |
| ICU Medical (ICUI) | United States | $3.141B | 20.47 |
| Prestige Consumer Healthcare (PBH) | United States | $2.676B | 12.62 |
| Haemonetics (HAE) | United States | $2.664B | 11.65 |
| LeMaitre Vascular (LMAT) | United States | $2.611B | 48.16 |
| Phibro Animal Health (PAHC) | United States | $2.347B | 20.67 |
| GN Store Nord (GNNDY) | Denmark | $2.270B | 21.90 |
| Neogen (NEOG) | United States | $2.050B | 44.86 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $2.028B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $1.794B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.654B | 32.89 |
| Curaleaf Holdings (CURLF) | Canada | $1.584B | 0.00 |
| Perrigo (PRGO) | Ireland | $1.495B | 3.96 |
| AtriCure (ATRC) | United States | $1.429B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.386B | 15.91 |
| Kestra Medical Technologies (KMTS) | United States | $1.043B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.953B | 164.50 |
| QuidelOrtho (QDEL) | United States | $0.943B | 6.53 |
| Lumexa Imaging Holdings (LMRI) | United States | $0.896B | 0.00 |
| InMode (INMD) | Israel | $0.857B | 9.40 |
| Omeros (OMER) | United States | $0.827B | 6.49 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.789B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.766B | 0.00 |
| CeriBell (CBLL) | United States | $0.683B | 0.00 |
| Brainsway (BWAY) | Israel | $0.546B | 55.68 |
| Valneva SE (VALN) | France | $0.532B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.468B | 11.18 |
| Cresco Labs (CRLBF) | United States | $0.458B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.424B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.415B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.367B | 25.70 |
| SNDL (SNDL) | Canada | $0.366B | 0.00 |
| Cerus (CERS) | United States | $0.363B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.311B | 126.00 |
| Evolus (EOLS) | United States | $0.278B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.259B | 0.00 |
| MacroGenics (MGNX) | United States | $0.229B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Accendra Health (ACH) | United States | $0.215B | 2.96 |
| Utah Medical Products (UTMD) | United States | $0.210B | 18.94 |
| High Tide (HITI) | Canada | $0.205B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.205B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.194B | 57.17 |
| TerrAscend (TSNDF) | Canada | $0.193B | 0.00 |
| Organigram Global (OGI) | Canada | $0.191B | 0.00 |
| Apyx Medical (APYX) | United States | $0.166B | 0.00 |
| Quanterix (QTRX) | United States | $0.158B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.152B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.145B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.143B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.133B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.53 |
| Jushi Holdings (JUSHF) | United States | $0.101B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.090B | 11.73 |
| Exagen (XGN) | United States | $0.073B | 0.00 |
| Sharps Technology (STSS) | United States | $0.065B | 0.00 |
| ImmuCell (ICCC) | United States | $0.064B | 0.00 |
| Biote (BTMD) | United States | $0.063B | 3.46 |
| INLIF (INLF) | China | $0.053B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.038B | 0.00 |
| Veru (VERU) | United States | $0.038B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.036B | 0.00 |
| Nephros (NEPH) | United States | $0.032B | 26.91 |
| United-Guardian (UG) | United States | $0.030B | 14.23 |
| Bonk (BNKK) | United States | $0.021B | 0.00 |
| Jin Medical (ZJYL) | China | $0.018B | 0.00 |
| Modular Medical (MODD) | United States | $0.013B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Agape ATP (ATPC) | $0.003B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.001B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |